NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/24/2022
Back to search
Official data from USPTO
AMLYCAS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
05/24/2022
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/20/2017
Registration date
05/24/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
77
Owner location
Grand Canal Docklands, Dublin 2, IE
Examiner
BLANDU, FLORENTINA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Prothena Biosciences Limited
Prothena Therapeutics Limited
Representatives
Jennifer L. Dean FAEGRE DRINKER BIDDLE & REATH LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of autoimmunemetastatichematologiconcologicocular and neurologic diseasesconditions and disorders; Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of diseasesconditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of diseasesconditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of amyloidosispsoriasispsoriatic arthritisrheumatoid arthritisdermatitishost and graft rejectionsAlzheimer's and Parkinson's-disease associated neuropsychiatric disordersinsulin resistancemetabolic syndrome and diabetes
Publications
History of USPTO decisions and trademark events.
51 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/04/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
03/30/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
03/30/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/14/2021
EX5G
SOU EXTENSION 5 GRANTED
12/13/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/13/2021
EXT5
SOU EXTENSION 5 FILED
12/02/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/02/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/04/2021
EX4G
SOU EXTENSION 4 GRANTED
06/02/2021
EXT4
SOU EXTENSION 4 FILED
06/02/2021
EEXT
SOU TEAS EXTENSION RECEIVED
06/02/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/04/2020
EX3G
SOU EXTENSION 3 GRANTED
12/02/2020
EXT3
SOU EXTENSION 3 FILED
12/02/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/13/2020
EX2G
SOU EXTENSION 2 GRANTED
11/12/2020
PCGR
PETITION TO DIRECTOR GRANTED
07/23/2020
APET
ASSIGNED TO PETITION STAFF
07/23/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/18/2020
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
06/12/2020
EXT2
SOU EXTENSION 2 FILED
06/04/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/04/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/05/2019
EX1G
SOU EXTENSION 1 GRANTED
12/03/2019
EXT1
SOU EXTENSION 1 FILED
12/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/03/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/04/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2019
PUBO
PUBLISHED FOR OPPOSITION
04/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
03/06/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/01/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/25/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/25/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/21/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/02/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/02/2018
CNSI
SUSPENSION INQUIRY WRITTEN
09/02/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/09/2018
ALIE
ASSIGNED TO LIE
08/09/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/19/2018
GNSL
LETTER OF SUSPENSION E-MAILED
01/19/2018
CNSL
SUSPENSION LETTER WRITTEN
01/19/2018
DOCK
ASSIGNED TO EXAMINER
01/19/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/30/2017
NWAP
NEW APPLICATION ENTERED
10/24/2017
Continuous trademark protection
Get notified about every new filing that threatens AMLYCAS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.